NEJM Study of Gen-Probe Assay Backs Use of Triplex NAT in HBV Blood Screening

Nucleic acid testing of blood donations using Gen-Probe's and Novartis' Procleix Ultrio assay revealed a higher-than-expected rate of HBV infection in blood donors, including those who had been previously vaccinated and who would not have been identified by routine antibody screening, according to the study.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.